ADAR and dysplasia: Importantly, the number of malignancy-associated HPV types identified was not significantly different (p > 0.05) between groups of recurrent and non-recurrent HPV-associated dysplasia, indicating that ADAR1 was an independent factor from higher prevalence of oncogenic HPV types.